Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details 3)

v3.8.0.1
Stockholders' Equity (Details 3) - Common Stock Warrants [Member]
9 Months Ended
Sep. 30, 2017
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Balance at beginning | shares 1,991,293
Issued | shares 7,134,200
Exercised | shares (3,845)
Terminated | shares (172,070)
Balance at ending | shares 8,949,578
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Exercise Price [Roll Forward]  
Balance at beginning | $ / shares $ 13.00
Issued | $ / shares 2.20
Exercised | $ / shares 2.00
Terminated | $ / shares 32.77
Balance at ending | $ / shares $ 4.12